Erratum: Evolving Practice: X-Linked Agammaglobulinemia and Lung Transplantation (American Journal of Transplantation (2015) 15(4) (1110–1113), (S1600613522001873), (10.1111/ajt.13084));Evolving practice: X-linked agammaglobulinemia and lung transplantation

American Journal of Transplantation

Volumn 15, Issue 4, 2015, Pages 1110-1113

  Barnes, S ^a   Kotecha, S ^b   Douglass, J A ^c   Paul, E ^b   Hore Lacey, F ^d   Stirling, R ^d   Snell, G I ^b   Westall, G P ^b  

^a Southern Health   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ALFRED HOSPITAL   (Australia)

Author keywords

clinical research; immune modulation; immunosuppression; immunosuppressive regimens; lung transplantation; practice; pulmonology, rejection: chronic

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; BASILIXIMAB; CLINDAMYCIN; COTRIMOXAZOLE; CYCLOSPORIN; DOXYCYCLINE; IMMUNOGLOBULIN; MOXIFLOXACIN; PREDNISOLONE; SPECTINOMYCIN; STEROID; TACROLIMUS; VALGANCICLOVIR;

ADULT; ARTICLE; ASPERGILLUS FUMIGATUS; BRONCHIECTASIS; BRONCHIOLITIS OBLITERANS; CANDIDA; CANDIDA ALBICANS; CLINICAL ARTICLE; CLINICAL TRIAL; FORCED EXPIRATORY VOLUME; GIARDIA INTESTINALIS; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; HUMAN TISSUE; KLEBSIELLA PNEUMONIAE; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORAXELLA CATARRHALIS; MYCOBACTERIUM; MYCOPLASMA HOMINIS; PRIMARY GRAFT DYSFUNCTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY FAILURE; SEPSIS; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; X LINKED AGAMMAGLOBULINEMIA; AGAMMAGLOBULINEMIA; CASE REPORT; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; X CHROMOSOME LINKED DISORDER;

ADULT; AGAMMAGLOBULINEMIA; GENETIC DISEASES, X-LINKED; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 84925305956     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13441     Document Type: Erratum

References (9)

1. Morales P, Hernandez D, Vicente R, et al. Lung transplantation in patients with X linked Agammaglobulinemia. Transpl Proceedings 2003; 35: 1942-1943.
2. Snell GI, Esmore DS, Westall GP, et al. The Alfred Hospital lung transplant experience. Clin Transpl 2007; 131-144.
3. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria. J Heart Lung Transplant 2002; 21: 297-310.
4. Verleden GM, Raghu G, Meyer KC, Glanville AR, Corris P., A new classification for chronic lung allograft dysfunction. J Heart Lung Transplant 2014; 33: 127-133.
5. Stewart S, Fishbein MC, Snell GI, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007; 26: 1229-1242.
6. Robertson J, Elidemir O, Saz EU, et al. Hypogammaglobilinemia: Incidence, risk factors, and outcomes following pediatric lung transplantation. Pediatr Transplant 2009; 13: 754-759.
7. Kuwut S, Shah L, Wilt JS, et al. Risk factors and outcomes of hypogammaglobulinemia after lung transplantation. Transplantation 2005; 79: 1723-1726.
8. Yip NH, Lederer DJ, Kawut SM, et al. Immunoglobulin G levels before and after lung transplantation. Am J Respir Crit Care Med 2006; 173: 917-921.
9. Chambers DC, Davies B, Mathews A, Yerkovich ST, Hopkins PM., Bronchiolitis obliterans syndrome, hypogammaglobulinemia, and infectious complications of lung transplantation. J Heart Lung Transplant 2013; 32: 36-43.